Trial NCT00506948

View at ClinicalTrials.gov 
Org. Study IDs: 2006-0435

Last trial update was posted on 2020-09-24

MeSH Interventions

Antilymphocyte Serum Mycophenolic Acid Sirolimus Thymoglobulin

MeSH Conditions

Hematologic Neoplasms Myelodysplastic Syndromes Neoplasms Preleukemia

Other Conditions

Hematological Malignancies Leukemia Lymphoma Myelodysplastic Syndrome

Stopping Reasons

Halted due to high incidence of veno-oclusive disease of the liver.

Limitations And Caveats

A decision to terminate this trial was made due to the high incidence of veno-occlusive disease of the liver in participants receiving this graft-versus-host disease (GVHD) prophylaxis regimen.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID